Abstract

Bumetanide 0.25-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2014 - Volume 18, Number 1

Page(s): 61

Download in electronic PDF format for $75
  • Bumetanide 0.25-mg/mL Injection Page 1

Abstract

A formulation for preparing Bumetanide 0.25-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • bumetanide
  • sterile compounding
  • compounded sterile preparation
  • diuretic
  • edema
  • congestive heart failure
  • hepatic disease
  • liver disorders
  • ascites
  • kidney disorders
  • renal disease
  • nephrotic syndrome
  • hypertension
  • high blood pressure
  • antihypertensive agent

Related Categories

  • FORMULATIONS
  • STERILE PREPARATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2014
Pg. 61
Bumetanide 0.25-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
May/Jun 2014
Pg. 233
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 414-417
Stability of Furosemide 5 mg/mL in Polypropylene Syringes
Author(s): van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Sep/Oct 2009
Pg. 367-371
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Author(s): Williams LaVonn A, Riley Kari
Sep/Oct 2019
Pg. 399-402
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Sep/Oct 2010
Pg. 382-394
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Author(s): Meadows Richard L, Muller George
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2022
Pg. 41-49
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 248-254
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
Mar/Apr 2017
Pg. 133-142
Accuracy Considerations in Sterile Compounding
Author(s): Akers Michael J